Thomas Tu - 27 Dec 2022 Form 4 Insider Report for Inari Medical, Inc.

Role: Chief Medical Officer
Signature: /s/ Angela Ahmad, attorney-in-fact for Thomas Tu
Issuer symbol: N/A
Transactions as of: 27 Dec 2022
Net transactions value: -$628,302
Form type: 4
Filing time: 28 Dec 2022, 15:32:38 UTC
Previous filing: 30 Nov 2022
Next filing: 04 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NARI	Common Stock	Options Exercise	$4,570	+10,000	+12%	$0.4570^*	96,451	27 Dec 2022	Direct	F1
transaction	NARI	Common Stock	Sale	$409,695	-6,529	-6.8%	$62.75	89,922	27 Dec 2022	Direct	F1, F2
transaction	NARI	Common Stock	Sale	$119,519	-1,871	-2.1%	$63.88	88,051	27 Dec 2022	Direct	F1, F3
transaction	NARI	Common Stock	Sale	$90,524	-1,400	-1.6%	$64.66	86,651	27 Dec 2022	Direct	F1, F4
transaction	NARI	Common Stock	Sale	$13,134	-200	-0.23%	$65.67	86,451	27 Dec 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NARI	Stock Option	Options Exercise	$0	-10,000	-5.9%	$0.000000	159,584	27 Dec 2022	Common Stock	10,000	$0.4570	Direct	F1, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022.
F2	This transaction was executed in multiple trades at prices ranging from $62.39 to $63.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3	This transaction was executed in multiple trades at prices ranging from $63.39 to $64.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4	This transaction was executed in multiple trades at prices ranging from $64.43 to $64.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5	The option vested with respect to 25% of the underlying shares on April 23, 2020, and vests with respect to the remaining shares in 36 equal monthly installments thereafter.